Browse > Article

THE STUDY OF BONE MINERAL DENSITY IN THE MANDIBLE OF STREPTOZOTOCIN-INDUCED DIABETIC RATS  

Jeong, Seok-Young (Dept. of Oral and Maxillofacial Surgery, Collage of Medicine, Dong-A University)
Shin, Sang-Hun (Dept. of Oral and Maxillofacial Surgery, Collage of Dentistry, Pusan National University)
Kim, Uk-Kyu (Dept. of Oral and Maxillofacial Surgery, Collage of Dentistry, Pusan National University)
Park, Bong-Soo (Dept of Oral Anatomy, Collage of Dentistry, Pusan National University)
Chung, In-Kyo (Dept. of Oral and Maxillofacial Surgery, Collage of Dentistry, Pusan National University)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.28, no.2, 2002 , pp. 95-102 More about this Journal
Abstract
DM is a systemic disease with many complications. One of them, diabetic osteopenia is important sequelae and many authors reported reduced bone mass in diabetic rats. However, in mandible, study has been rare because of its anatomical limits. So the objective of this study was to investigate bony change in mandible of diabetic rats. Thirty-two adult rats were used in this study. Half of them were male and female respectively. In sixteen rats, streptozotocin was injected intraperitoneally to induce DM and the serum glucose concentration was checked to ensure the induction of DM prior to the time of sacrifice. At 1, 2, 3, 4, 6, 8, 12, 16weeks, control group and diabetic group rats were sacrificed respectively. And then bone mineral density of mandibles and femurs of the rats was measured using dual energy X-ray absorptiometry(DEXA). In addition serum osteocalcin and urine deoxypyridinoline were measured as markers of bone formation and resoption respectively. Mandibular and femoral bone density in streptozotocin induced rats was decreased with significance statistically after 4 weeks from injection. In mandible, comparing with femur, bone density was moderately decreased. The alveolar bone in mandible was more decreased bone density than the whole body in the mandible From these results, bone mineral density decreased in uncontrolled diabetic group with time, and especially alveolar bone was more destructive in the mandible. So authors think that consideration of reduced bone mineral density is necessary in dental procedure.
Keywords
DM; Osteoporosis; DEXA; Bone density;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Albright F, Reinfenstein EC: The parathyriod glands and metabolic bone disease. Baltimore, Wiliams and Wilkins, 1948
2 Grag A. Bonanome A. Grundy SM, Unger RH, Breslau NA, Pak CY. Effects of diatary carbohydrates on metabolism of calcium and other minerals in normal subjects and patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1990; 70: 1007-1013
3 Kao CH, Tsou CT, Chen CC, Wang SJ: Bone mineral density in patients with non-insulin-dependent diabetes mellitus by dual photon absorptiometry. Nucl Med Commun 1993; 14:373-377   DOI   ScienceOn
4 강무일 : 골교체 생화학적 표지자의 임상적 응용. 대한 골대사학회지 1994; 1: 246-253
5 De Pommereu V, Dargent-Pare, Robert JJ, Brion M : Periodontal status in insulin-dependent diabetic adolescents. J Periodontol 1992; 19; 628-632
6 Rylander H, Ranberg P, Blohme G, Lindhe J : Prevalence of periodontal disease in young diabetics. J Clin Periodontol 1987; 14; 38-43
7 Kimink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG : Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest 2000; 23: 295-303
8 민헌기 : 한국인 당뇨병의 임상적 특성. 당뇨병 1992; 16: 163-174
9 Kanzaki S, Hosoda K, Moriwake T, Tanaka H, Kubo T, Inoue M, Higuchi J, Yahaji T, Seino Y : Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone(GH) deficiency : A potential marker of bone growth and response to GH therapy. J Clin Endovrinol Metab 1992; 75; 1104-1109
10 Delmas PD : Biochemical markers of bone turnover for the clinical assessment of metabolic disease. Endocrinol Metab Clin North Am 1990; 19; 1-18
11 Rosenquist C, Qvist P, Bjarnason N, Christianson C: measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem 1995; 41: 1439-1445   PUBMED
12 Emrich LJ, Shlossman M, Genco RJ : Periodontal disease in noninsulin-dependent diabetes mellitus. J Periodontol 62; 123-130
13 Eyre DR, Dickson IR, Van Nes KP : Collagen cross-linking in human bone and articular cartilage; age-related change in the content of mature hydroxy-pyridinium residues. Biochem J 1988; 252; 495-500
14 Ituarte EA, Itularte HG, Hahn TJ: Insulin and glucose regulation of glycogen synthase in rat calvarial osteoblast like cells. Calcif Tissue Int 1988; 42:651-657
15 Johnston CC Jr, Hui SL, Longcope C : Bone mass and sex steroid concentrations inpostmenopausal Cauasian diabetics, Metabolism 1989; 34: 544-550
16 Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM: Bone lose and bone turnover in diabetes. Diabetes 1995; 44:775-782   DOI   ScienceOn
17 Glajchen N, Epstein S, Ismail F, Thomas S, Fallon M, Chakrabarti S : Bone mineral metabolism in experimental diabetes mellitus : osteocalcin as a measure of bone remodeling Encocrinol 1988; 123; 290-295
18 Agarval MKL: Theory and Practice. In Rifkin H, Porte D(eds): Ellenberg and Rifkin’s Diabetic Mellitus. 4th ed, New York, Elsevier Science Publishing Co., Inc. 1991, p 301
19 Garnero P, Delmas PD : New developments in biochemical markers for osteoporosis. Calcif Tissue Int Suppl 1996; 1; S2-S9
20 Martineau-Doize B, Mckee MD, Warshawsky H, Bergeron JJ: In vivo demonstration by radioautography of binding sites for insulin in liver, kidney, and calcified tissue of the rat. Anat Rec 1986; 214: 130-140   DOI   ScienceOn
21 Blumsohn A, Hannon RA, Eastell R : Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays. Clin Chem 1995; 41; 318-319
22 Ziegler R. : Diabetes mellitus and bone metabolism. Hormone & metabolic Research-Supplement 1992; 26: 90-94
23 Nagasaki S, Murakami T, Uchikawa T, Ishikawa SE, Saito T: Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus. Endocrine J 1995; 42:377-383   DOI   ScienceOn
24 Price PA, Parthermore JG, Doftos LJ : New biochemical marker for bone metabolism. J Clin Invest 1980; 66: 878-883   DOI   PUBMED   ScienceOn
25 Sosa M, Dominguez M, Navarro MC, Segarra MC, Hernandez D, de Pablos P, Betancor P : Bone mineral metabolism is normal in noninsulin- dependent diabetes mellitus. J Diabetes Complications 1996; 10: 201-205   DOI   ScienceOn
26 Delmas PD, Chatelain P, Malabal L : Serum bone GLA-protein in growth hormone deficient children. J Bone Miner Res 1986; 1; 333-338
27 Malone JI, Lowitt S, Duncan JA, Shah SC, Vargas A, Root AW: Hypercalciuria, hyperphosphaturia, and growth retardation in children with diabetes mellitus. Pediatrics 1986; 78 : 298- 304   PUBMED
28 신찬수 등 : 경기도 연천지역에서 당뇨병의 발생률. 당뇨병 1996; 20: 264-272
29 Gala Paniagua J, Diaz-Curiel M, de la Piedra Gordo C, Castilla Reparaz C, Torralbo Garcia M: Bone mass assessment in rats by dual energy X-ray absorptiometry. Br J Radiol 1998; 71: 754-758   DOI   PUBMED
30 McNair P: Bone mineral metabolism in human type 1(insulin dependent) diabetes mellitus. Danish Med Bull. 1988; 35:109-121
31 Holdsworth DW, Thornton MM, Drost D, Watson PH, Fraher LJ, Hodsman AB : Rapid small-animal dual-energy X-ray absorptiometry using digital radiography. J Bone Miner Res. 2000; 15: 2451-2457   DOI   ScienceOn
32 이기업: 제1형 당뇨병의 실험동물 모델. 당뇨병 1990; 14:143-150
33 Saggese G, Bertelloni S, Baroncelli GI, Federico G, Calisti L, Fusaro C: Bone demineralization and impaired mineral metabolism in insulin-dependent diabetes mellitus. A possible role of magnesium deficiency. Helv Paediatr Acta 1989; 43:405-414   PUBMED
34 Storm TL, Lund B, Christiansen JS, Andersen AR, Lumholtz IB, Parving HH: Vitamin D metabolism in insulin-dependent diabetes mellitus. Metab Bone Dis Relat Res 1983-1984; 5:107-110   DOI   ScienceOn
35 Reiner, A : Oral complication of diabetes. Dent Ann. 1977; 36: 46-52
36 Miazgowski T, Andrysiak Mamos E, Czekalski S, Pynka S: Decreased bone mineral density in patients with insulin-dependent-diabetes. Pol Tyg Lek 1995; 50:44-47